Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

New Zealand (NZX) Healthcare Sector Analysis

UpdatedAug 19, 2026
DataAggregated Company Financials
Companies14
  • 7D-0.9%
  • 3M20.5%
  • 1Y-3.6%
  • YTD-0.9%

Last week, the Healthcare industry hasn't moved much but EBOS Group is up 7.7% in that time. Unfortunately though, the industry is down 3.6% over the past 12 months. Looking forward, earnings are forecast to grow by 20% annually.

Sector Valuation and Performance

Has the New Zealand Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 19 Aug 2026NZ$35.0bNZ$20.1bNZ$828.0m16.9x42.2x1.7x
Fri, 17 Jul 2026NZ$33.7bNZ$20.0bNZ$825.2m17x40.9x1.7x
Sun, 14 Jun 2026NZ$33.5bNZ$20.1bNZ$828.0m16.2x40.4x1.7x
Tue, 12 May 2026NZ$30.6bNZ$20.0bNZ$452.4m18.2x67.5x1.5x
Thu, 09 Apr 2026NZ$33.4bNZ$19.9bNZ$450.5m17.8x74.1x1.7x
Sat, 07 Mar 2026NZ$34.9bNZ$19.6bNZ$446.1m17.8x78.2x1.8x
Mon, 02 Feb 2026NZ$35.2bNZ$18.3bNZ$533.9m19.9x65.9x1.9x
Wed, 31 Dec 2025NZ$35.2bNZ$18.3bNZ$533.6m20.4x65.9x1.9x
Fri, 28 Nov 2025NZ$35.8bNZ$18.1bNZ$530.9m21.8x67.4x2x
Sun, 26 Oct 2025NZ$33.9bNZ$17.7bNZ$574.0m19x59.1x1.9x
Tue, 23 Sep 2025NZ$34.4bNZ$17.7bNZ$572.5m18.2x60x1.9x
Thu, 21 Aug 2025NZ$36.4bNZ$17.7bNZ$574.0m18.6x63.4x2.1x
Sat, 19 Jul 2025NZ$36.1bNZ$17.6bNZ$571.1m17.7x63.2x2.1x
Mon, 16 Jun 2025NZ$34.8bNZ$17.4bNZ$567.9m14.8x61.3x2x
Wed, 14 May 2025NZ$35.4bNZ$17.4bNZ$656.4m15.3x54x2x
Fri, 11 Apr 2025NZ$34.0bNZ$17.3bNZ$656.1m15.3x51.9x2x
Sun, 09 Mar 2025NZ$33.5bNZ$17.6bNZ$660.5m16.9x50.8x1.9x
Tue, 04 Feb 2025NZ$36.0bNZ$18.2bNZ$734.3m14.8x49x2x
Thu, 02 Jan 2025NZ$37.1bNZ$18.2bNZ$728.8m12.9x51x2x
Sat, 30 Nov 2024NZ$37.0bNZ$18.2bNZ$733.2m14.1x50.4x2x
Mon, 28 Oct 2024NZ$37.6bNZ$18.3bNZ$968.4m20x38.9x2.1x
Wed, 25 Sep 2024NZ$35.6bNZ$18.1bNZ$964.0m19.5x36.9x2x
Fri, 23 Aug 2024NZ$34.3bNZ$18.1bNZ$988.9m20.4x34.7x1.9x
Sun, 21 Jul 2024NZ$32.3bNZ$17.8bNZ$978.1m17.1x33x1.8x
Tue, 18 Jun 2024NZ$30.3bNZ$17.3bNZ$960.7m17.3x31.5x1.7x
Thu, 16 May 2024NZ$30.0bNZ$17.4bNZ$1.3b23.4x23.3x1.7x
Sat, 13 Apr 2024NZ$29.7bNZ$17.3bNZ$1.3b24.2x23.1x1.7x
Mon, 11 Mar 2024NZ$29.0bNZ$17.1bNZ$1.3b18.6x22.6x1.7x
Wed, 07 Feb 2024NZ$30.0bNZ$16.6bNZ$1.1b18.7x26.6x1.8x
Fri, 05 Jan 2024NZ$29.3bNZ$16.7bNZ$1.1b23.4x25.9x1.8x
Sun, 03 Dec 2023NZ$28.8bNZ$16.6bNZ$1.1b24.1x25.4x1.7x
Tue, 31 Oct 2023NZ$26.9bNZ$16.6bNZ$1.1b23.8x24.2x1.6x
Thu, 28 Sep 2023NZ$28.3bNZ$16.4bNZ$1.1b29x25.6x1.7x
Sat, 26 Aug 2023NZ$28.8bNZ$16.5bNZ$1.1b28.8x26.3x1.7x
Price to Earnings Ratio

26.3x


Total Market Cap: NZ$28.8bTotal Earnings: NZ$1.1bTotal Revenue: NZ$16.5bTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Healthcare Sector Price to Earnings3Y Average 45.3x202420252026
Current Industry PE
  • Investors are pessimistic on the New Zealander Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 42.2x which is lower than its 3-year average PE of 45.3x.
  • The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 8.9% per year over the last three years.
  • Meanwhile revenues for these companies have grown 6.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the New Zealand Healthcare sector?

NZ Market0.28%
Healthcare-0.91%
Medical Equipment-0.77%
Healthcare Services-0.96%
Biotech-1.96%
Pharma-5.70%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 81.3x.
    • Analysts are expecting annual earnings growth of 13.3%, which is lower than the prior year's growth of 24.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 65% over the next 5 years.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EBO EBOS GroupNZ$23.557.7%
+NZ$347.7m		-41.5%PE17.6x
FPH Fisher & Paykel HealthcareNZ$42.500.7%
+NZ$164.4m		12.9%PE53.3x
RYM Ryman HealthcareNZ$2.102.4%
+NZ$50.7m		-13.2%PS2.5x
RAD Radius Residential CareNZ$0.4817.1%
+NZ$19.8m		26.3%PE14.4x
OCA Oceania HealthcareNZ$0.801.3%
+NZ$7.2m		20.5%PE4838.4x

Latest News

RAD
NZ$0.48
Radius Residential Care
7D
17.1%
1Y
26.3%
Analysis Article • Aug 17

Should You Be Adding Radius Residential Care (NZSE:RAD) To Your Watchlist Today?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
EBO
NZ$23.55
EBOS Group
7D
7.7%
1Y
-41.5%
Narrative Update • Aug 13

EBO: Higher Required Returns Will Temper Margin Outlook Yet Keep Shares Steady

Analysts have trimmed their price target for EBOS Group from NZ$23.77 to NZ$22.81, citing updated assumptions for the discount rate, profit margin, revenue growth and future P/E, which together point to a slightly lower fair value estimate. What's in the News for EBOS Group No recent company specific news items for EBOS Group were identified in the provided sources up to 13 August 2026.
RUA
NZ$0.033
Rua Bioscience
7D
3.1%
1Y
-28.3%
FPH
NZ$42.50
Fisher & Paykel Healthcare
7D
0.7%
1Y
12.9%
Narrative Update • Aug 08

FPH: Conviction List Removal And Rich Multiple Will Pressure Shares

Analysts have nudged their fair value estimate for Fisher & Paykel Healthcare to NZ$31.37 from NZ$30.59, reflecting updated assumptions on growth, profitability and P/E multiples after the stock was removed from a regional conviction list in recent research. What’s in the News for Fisher & Paykel Healthcare Fisher & Paykel Healthcare declared a dividend of NZ$0.38823529 per share for the six months ended March 31, 2026.
PHL
NZ$0.74
Promisia Healthcare
7D
-1.3%
1Y
85.0%
AFT
NZ$4.40
AFT Pharmaceuticals
7D
-2.7%
1Y
69.2%
SUM
NZ$7.86
Summerset Group Holdings
7D
-4.5%
1Y
-28.0%
RYM
NZ$2.10
Ryman Healthcare
7D
2.4%
1Y
-13.2%
MEE
NZ$0.062
Me Today
7D
21.6%
1Y
-15.1%
PEB
NZ$0.26
Pacific Edge
7D
-3.8%
1Y
100.8%
OCA
NZ$0.80
Oceania Healthcare
7D
1.3%
1Y
20.5%
Narrative Update • Jun 26

OCA: Revised Assumptions Will Temper Expectations While Supporting Steady Future Earnings

Analysts have revised their fair value estimate for Oceania Healthcare from about NZ$0.84 to around NZ$0.72. This reflects updates to the discount rate, revenue growth, profit margin and future P/E assumptions used in their valuation work.